ArticleScience advances2026

PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity.

Neus Martínez-Bosch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.